Consensus guidelines on the use of Superficial Radiation Therapy (SRT) for treating both NMSC and recurrent keloid scars were published recently in The Journal of Clinical and Aesthetic Dermatology, announces Sensus Healthcare Inc in a media release.

Consensus was reached for guidelinesĀ on various aspects of SRT use, including appropriate tumor types; suitable anatomical areas; energy, fractions, and scheduling recommendations for SRT; safety factors; as well as treatment recommendations for keloid scars, based the literature and on both the opinions of the expert group and a survey of experienced users.

The expert group that developed the guidelines has a combined 250 years of dermatology practice and 78 years of experience with SRT specifically, having treated more than 9,000 patients with SRT, the release explains.

“With decades of clinical use and research, 1000+ doctors around the world use SRT as a highly effective, non-invasive treatment option for NMSC and keloid scars for their patients. It is vital that the medical community has clear, concise, published treatment guidelines based on a thorough review of all literature and expert opinion on SRT to date,” says Mark S. Nestor, MD, PHD, director, Center for Clinical and Cosmetic Research, Aventura Fla and Voluntary Professor, the Department of Dermatology and Cutaneous Surgery and Department of Surgery, Division of Plastic Surgery at University of Miami Miller School of Medicine, and the lead author of the guideline, in the release.

“Our goal in forming these guidelines is to fill an important knowledge gap regarding the use of SRT and demonstrate its overarching efficacy with various patient populations across the globe,” he adds.

[Source(s): Sensus Healthcare, PR Newswire]